Third Harmonic Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch THRD and buy or sell other stocks, ETFs, and their options commission-free!About THRD
Third Harmonic Bio, Inc. develops pharmaceutical products for the treatment of allergic and immune diseases and disorders. It focuses on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases.
CEONatalie C. Holles
CEONatalie C. Holles
Employees53
Employees53
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded2019
Founded2019
Employees53
Employees53
THRD Key Statistics
Market cap241.86M
Market cap241.86M
Price-Earnings ratio-4.33
Price-Earnings ratio-4.33
Dividend yield—
Dividend yield—
Average volume141.80K
Average volume141.80K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$16.02
52 Week high$16.02
52 Week low$3.18
52 Week low$3.18
Stock Snapshot
The current Third Harmonic Bio(THRD) stock price is $5.38, with a market capitalization of 241.86M. The stock trades at a price-to-earnings (P/E) ratio of -4.33.
On 2025-12-17, Third Harmonic Bio(THRD) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 141.8K.
Over the past 52 weeks, Third Harmonic Bio(THRD) stock has traded between a high of $16.02 and a low of $3.18.
Over the past 52 weeks, Third Harmonic Bio(THRD) stock has traded between a high of $16.02 and a low of $3.18.
People also own
Based on the portfolios of people who own THRD. This list is generated using Robinhood data, and it’s not a recommendation.